High signal intensity on diffusion-weighted magnetic resonance images is a useful finding for detecting early-stage pancreatic cancer

1.

Kamisawa T, Wood LD, Itoi T, Takaori K (2016) Pancreatic cancer. Lancet. 388(10039):73-85. https://doi.org/10.1016/S0140-6736(16)00141-0

CAS  Article  PubMed  Google Scholar 

2.

Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin. 68(1):7-30. https://doi.org/10.3322/caac.21442

Article  PubMed  Google Scholar 

3.

Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM (2014) Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 74(11):2913-2921. https://doi.org/10.1158/0008-5472.CAN-14-0155

CAS  Article  PubMed  Google Scholar 

4.

Egawa S, Toma H, Ohigashi H, Okusaka T, Nakao A, Hatori T, Maguchi H, Yanagisawa A, Tanaka M (2012) Japan Pancreatic Cancer Registry; 30th year anniversary: Japan Pancreas Society. Pancreas. 41(7):985-992. https://doi.org/10.1097/MPA.0b013e318258055c

Article  PubMed  Google Scholar 

5.

Kanno A, Masamune A, Hanada K, Maguchi H, Shimizu Y, Ueki T, Hasebe O, Ohtsuka T, Nakamura M, Takenaka M, Kitano M, Kikuyama M, Gabata T, Yoshida K, Sasaki T, Serikawa M, Furukawa T, Yanagisawa A, Shimosegawa T, Japan Study Group on the Early Detection of Pancreatic C (2018) Multicenter study of early pancreatic cancer in Japan. Pancreatology. 18(1):61-67. https://doi.org/10.1016/j.pan.2017.11.007

Article  PubMed  Google Scholar 

6.

Sakamoto H, Kitano M, Dote K, Tchikugo T, Takeyama Y, Kudo M (2008) In situ carcinoma of pancreas diagnosed by EUS-FNA. Endoscopy. 40 Suppl 2:E15-16. https://doi.org/10.1055/s-2007-966708

Article  PubMed  Google Scholar 

7.

Seki M, Ninomiya E, Hayashi K, Gotoh H, Koga R, Saiura A, Yamada K, Katori M, Kato Y, Okamura H (2010) Widespread and multifocal carcinomas in situ (CISs) through almost the entire pancreas: report of a case with preoperative cytological diagnosis. Langenbecks Arch Surg. 395(5):589-592. https://doi.org/10.1007/s00423-009-0579-4

Article  PubMed  Google Scholar 

8.

Inoue H, Katurahara M, Hamada Y, Ninomiya K, Tano S, Takayama R, Nojiri K, Tameda M, Horiki N, Takei Y (2012) Hemosuccus pancreaticus caused by in situ carcinoma of the pancreas. Endoscopy. 44 Suppl 2 UCTN:E336–337. https://doi.org/10.1055/s-0032-1309863

9.

Satoh T, Kikuyama M, Kawaguchi S, Kanemoto H, Muro H, Hanada K (2017) Acute pancreatitis-onset carcinoma in situ of the pancreas with focal fat replacement diagnosed using serial pancreatic-juice aspiration cytologic examination (SPACE). Clin J Gastroenterol. 10(6):541-545. https://doi.org/10.1007/s12328-017-0776-6

Article  PubMed  Google Scholar 

10.

Yamao K, Takenaka M, Nakai A, Omoto S, Kamata K, Minaga K, Miyata T, Imai H, Sakurai T, Watanabe T, Nishida N, Matsumoto I, Takeyama Y, Chikugo T, Kudo M (2017) Detection of High-Grade Pancreatic Intraepithelial Neoplasia without Morphological Changes of the Main Pancreatic Duct over a Long Period: Importance for Close Follow-Up for Confirmation. Oncology. 93 Suppl 1:81-86. https://doi.org/10.1159/000481237

Article  PubMed  Google Scholar 

11.

Miyata T, Takenaka M, Omoto S, Kamata K, Minaga K, Yamao K, Imai H, Kudo M (2017) A Case of Pancreatic Carcinoma in situ Diagnosed by Repeated Pancreatic Juice Cytology. Oncology. 93 Suppl 1:98-101. https://doi.org/10.1159/000481240

Article  PubMed  Google Scholar 

12.

Yokode M, Akita M, Fujikura K, Kim MJ, Morinaga Y, Yoshikawa S, Terada T, Matsukiyo H, Tajiri T, Abe-Suzuki S, Itoh T, Hong SM, Zen Y (2018) High-grade PanIN presenting with localised stricture of the main pancreatic duct: A clinicopathological and molecular study of 10 cases suggests a clue for the early detection of pancreatic cancer. Histopathology. 73(2):247-258. https://doi.org/10.1111/his.13629

Article  PubMed  Google Scholar 

13.

Genkinger JM, Spiegelman D, Anderson KE, Bergkvist L, Bernstein L, van den Brandt PA, English DR, Freudenheim JL, Fuchs CS, Giles GG, Giovannucci E, Hankinson SE, Horn-Ross PL, Leitzmann M, Mannisto S, Marshall JR, McCullough ML, Miller AB, Reding DJ, Robien K, Rohan TE, Schatzkin A, Stevens VL, Stolzenberg-Solomon RZ, Verhage BA, Wolk A, Ziegler RG, Smith-Warner SA (2009) Alcohol intake and pancreatic cancer risk: a pooled analysis of fourteen cohort studies. Cancer Epidemiol Biomarkers Prev. 18(3):765-776. https://doi.org/10.1158/1055-9965.EPI-08-0880

CAS  Article  PubMed  PubMed Central  Google Scholar 

14.

Del Chiaro M, Zerbi A, Capurso G, Zamboni G, Maisonneuve P, Presciuttini S, Arcidiacono PG, Calculli L, Falconi M, Italian Registry for Familial Pancreatic C (2010) Familial pancreatic cancer in Italy. Risk assessment, screening programs and clinical approach: a position paper from the Italian Registry. Dig Liver Dis. 42(9):597–605. https://doi.org/10.1016/j.dld.2010.04.016

15.

Goral V (2015) Pancreatic Cancer: Pathogenesis and Diagnosis. Asian Pac J Cancer Prev. 16(14):5619-5624. https://doi.org/10.7314/apjcp.2015.16.14.5619

Article  PubMed  Google Scholar 

16.

Ilic M, Ilic I (2016) Epidemiology of pancreatic cancer. World J Gastroenterol. 22(44):9694-9705. https://doi.org/10.3748/wjg.v22.i44.9694

Article  PubMed  PubMed Central  Google Scholar 

17.

Paiella S, Salvia R, De Pastena M, Pollini T, Casetti L, Landoni L, Esposito A, Marchegiani G, Malleo G, De Marchi G, Scarpa A, D'Onofrio M, De Robertis R, Pan TL, Maggino L, Andrianello S, Secchettin E, Bonamini D, Melisi D, Tuveri M, Bassi C (2018) Screening/surveillance programs for pancreatic cancer in familial high-risk individuals: A systematic review and proportion meta-analysis of screening results. Pancreatology. 18(4):420-428. https://doi.org/10.1016/j.pan.2018.04.002

Article  PubMed  Google Scholar 

18.

Paiella S, Capurso G, Cavestro GM, Butturini G, Pezzilli R, Salvia R, Signoretti M, Crippa S, Carrara S, Frigerio I, Bassi C, Falconi M, Iannicelli E, Giardino A, Mannucci A, Laghi A, Laghi L, Frulloni L, Zerbi A (2019) Results of First-Round of Surveillance in Individuals at High-Risk of Pancreatic Cancer from the AISP (Italian Association for the Study of the Pancreas) Registry. Am J Gastroenterol. 114(4):665-670. https://doi.org/10.1038/s41395-018-0414-z

Article  PubMed  Google Scholar 

19.

Canto MI, Harinck F, Hruban RH, Offerhaus GJ, Poley JW, Kamel I, Nio Y, Schulick RS, Bassi C, Kluijt I, Levy MJ, Chak A, Fockens P, Goggins M, Bruno M, International Cancer of Pancreas Screening C (2013) International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer. Gut. 62(3):339-347. https://doi.org/10.1136/gutjnl-2012-303108

Article  PubMed  Google Scholar 

20.

Whitcomb DC, Shimosegawa T, Chari ST, Forsmark CE, Frulloni L, Garg P, Hegyi P, Hirooka Y, Irisawa A, Ishikawa T, Isaji S, Lerch MM, Levy P, Masamune A, Wilcox CM, Windsor J, Yadav D, Sheel A, Neoptolemos JP, Working Group for the International Consensus Guidelines for Chronic P (2018) International consensus statements on early chronic Pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with The International Association of Pancreatology, American Pancreatic Association, Japan Pancreas Society, PancreasFest Working Group and European Pancreatic Club. Pancreatology. https://doi.org/10.1016/j.pan.2018.05.008

21.

Kim SW, Kim SH, Lee DH, Lee SM, Kim YS, Jang JY, Han JK (2017) Isolated Main Pancreatic Duct Dilatation: CT Differentiation Between Benign and Malignant Causes. AJR Am J Roentgenol. 209(5):1046-1055. https://doi.org/10.2214/AJR.17.17963

Article  PubMed  Google Scholar 

22.

Fukukura Y, Fujiyoshi F, Sasaki M, Nakajo M (2002) Pancreatic duct: morphologic evaluation with MR cholangiopancreatography after secretin stimulation. Radiology. 222(3):674-680. https://doi.org/10.1148/radiol.2223010684

Article  PubMed  Google Scholar 

23.

James D. Brierley MKG, Christian Wittekind (2018) TNM Classification of Malignant nant Tumors. 8th ed. New York, NY: Wiley.

Google Scholar 

24.

Corral JE, Mareth KF, Riegert-Johnson DL, Das A, Wallace MB (2019) Diagnostic Yield From Screening Asymptomatic Individuals at High Risk for Pancreatic Cancer: A Meta-analysis of Cohort Studies. Clin Gastroenterol Hepatol. 17(1):41-53. https://doi.org/10.1016/j.cgh.2018.04.065

Article  PubMed  Google Scholar 

25.

Goggins M, Overbeek KA, Brand R, Syngal S, Del Chiaro M, Bartsch DK, Bassi C, Carrato A, Farrell J, Fishman EK, Fockens P, Gress TM, van Hooft JE, Hruban RH, Kastrinos F, Klein A, Lennon AM, Lucas A, Park W, Rustgi A, Simeone D, Stoffel E, Vasen HFA, Cahen DL, Canto MI, Bruno M, International Cancer of the Pancreas Screening c (2020) Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium. Gut. 69(1):7-17. https://doi.org/10.1136/gutjnl-2019-319352

26.

Dudley B, Brand RE (2019) Pancreatic Cancer Surveillance: Who, When, and How. Curr Treat Options Gastroenterol. 17(4):681-691. https://doi.org/10.1007/s11938-019-00247-0

Article  PubMed  Google Scholar 

27.

O'Neill RS, Meiser B, Emmanuel S, Williams DB, Stoita A (2020) Long-term positive psychological outcomes in an Australian pancreatic cancer screening program. Fam Cancer. 19(1):23-35. https://doi.org/10.1007/s10689-019-00147-3

CAS  Article  PubMed  Google Scholar 

28.

McGuigan A, Kelly P, Turkington RC, Jones C, Coleman HG, McCain RS (2018) Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes. World J Gastroenterol. 24(43):4846-4861. https://doi.org/10.3748/wjg.v24.i43.4846

Article  PubMed  PubMed Central  Google Scholar 

29.

Latenstein AEJ, van der Geest LGM, Bonsing BA, Groot Koerkamp B, Haj Mohammad N, de Hingh I, de Meijer VE, Molenaar IQ, van Santvoort HC, van Tienhoven G, Verheij J, Vissers PAJ, de Vos-Geelen J, Busch OR, van Eijck CHJ, van Laarhoven HWM, Besselink MG, Wilmink JW, Dutch Pancreatic Cancer G (2020) Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma. Eur J Cancer. 125:83-93. https://doi.org/10.1016/j.ejca.2019.11.002

CAS  Article  PubMed  Google Scholar 

30.

Brentnall TA, Bronner MP, Byrd DR, Haggitt RC, Kimmey MB (1999) Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer. Ann Intern Med. 131(4):247-255. https://doi.org/10.7326/0003-4819-131-4-199908170-00003

CAS  Article  PubMed  Google Scholar 

31.

Harinck F, Konings IC, Kluijt I, Poley JW, van Hooft JE, van Dullemen HM, Nio CY, Krak NC, Hermans JJ, Aalfs CM, Wagner A, Sijmons RH, Biermann K, van Eijck CH, Gouma DJ, Dijkgraaf MG, Fockens P, Bruno MJ, Dutch research group on pancreatic cancer surveillance in high-risk i (2016) A multicentre comparative prospective blinded analysis of EUS and MRI for screening of pancreatic cancer in high-risk individuals. Gut. 65(9):1505-1513. https://doi.org/10.1136/gutjnl-2014-308008

32.

Potjer TP, Schot I, Langer P, Heverhagen JT, Wasser MN, Slater EP, Kloppel G, Morreau HM, Bonsing BA, de Vos Tot Nederveen Cappel WH, Bargello M, Gress TM, Vasen HF, Bartsch DK, Leiden Familial Pancreatic Cancer G, FaPaCa r (2013) Variation in precursor lesions of pancreatic cancer among high-risk groups. Clin Cancer Res. 19(2):442-449. https://doi.org/10.1158/1078-0432.CCR-12-2730

33.

Iiboshi T, Hanada K, Fukuda T, Yonehara S, Sasaki T, Chayama K (2012) Value of cytodiagnosis using endoscopic nasopancreatic drainage for early diagnosis of pancreatic cancer: establishing a new method for the early detection of pancreatic carcinoma in situ. Pancreas. 41(4):523-529. https://doi.org/10.1097/MPA.0b013e31823c0b05

Article  PubMed  Google Scholar 

34.

Hanada K, Amano H, Abe T (2017) Early diagnosis of pancreatic cancer: Current trends and concerns. Ann Gastroenterol Surg. 1(1):44-51. https://doi.org/10.1002/ags3.12004

Article  PubMed  PubMed Central  Google Scholar 

35.

Ichikawa T, Erturk SM, Motosugi U, Sou H, Iino H, Araki T, Fujii H (2007) High-b value diffusion-weighted MRI for detecting pancreatic adenocarcinoma: preliminary results. AJR Am J Roentgenol. 188(2):409-414. https://doi.org/10.2214/AJR.05.1918

Article  PubMed  Google Scholar 

36.

Koh DM, Collins DJ (2007) Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol. 188(6):1622-1635. https://doi.org/10.2214/AJR.06.1403

Article  PubMed  Google Scholar 

37.

Tsushima Y, Takano A, Taketomi-Takahashi A, Endo K (2007) Body diffusion-weighted MR imaging using high b-value for malignant tumor screening: usefulness and necessity of referring to T2-weighted images and creating fusion images. Acad Radiol. 14(6):643-650. https://doi.org/10.1016/j.acra.2007.02.006

Article  PubMed  Google Scholar 

38.

Fattahi R, Balci NC, Perman WH, Hsueh EC, Alkaade S, Havlioglu N, Burton FR (2009) Pancreatic diffusion-weighted imaging (DWI): comparison between mass-forming focal pancreatitis (FP), pancreatic cancer (PC), and normal pancreas. J Magn Reson Imaging. 29(2):350-356. https://doi.org/10.1002/jmri.21651

Article  PubMed  Google Scholar 

39.

Kartalis N, Lindholm TL, Aspelin P, Permert J, Albiin N (2009) Diffusion-weighted magnetic resonance imaging of pancreas tumours. Eur Radiol. 19(8):1981-1990. https://doi.org/10.1007/s00330-009-1384-8

Article  PubMed  Google Scholar 

40.

Fukukura Y, Takumi K, Kamimura K, Shindo T, Kumagae Y, Tateyama A, Nakajo M (2012) Pancreatic adenocarcinoma: variability of diffusion-weighted MR imaging findings. Radiology. 263(3):732-740. https://doi.org/10.1148/radiol.12111222

Article 

留言 (0)

沒有登入
gif